(Q44197191)

30 November 2017

title

Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes (English)

1 reference

30 November 2017

1

1 reference

30 November 2017

language of work or name

1 reference

1 July 2002

1 reference

30 November 2017

published in

Human Psychopharmacology

1 reference

30 November 2017

volume

17

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

233-238

1 reference

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

30 November 2017

cites work

1 reference

Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors

21 January 2018

1 reference

Drug glucuronidation in clinical psychopharmacology

21 January 2018

1 reference

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence

21 January 2018

1 reference

The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers

21 January 2018

1 reference

Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes

21 January 2018

1 reference

Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service

21 January 2018

1 reference

Predicting drug interactions and pharmacokinetic variability with in vitro methods: the olanzapine experience

21 January 2018

1 reference

Olanzapine: interaction study with imipramine

21 January 2018

1 reference

7 January 2021

A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism

1 reference

7 January 2021

Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration

1 reference

7 January 2021

Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs

1 reference

7 January 2021

Olanzapine Serum Concentrations in Psychiatric Patients Given Standard Doses: The Influence of Comedication

1 reference

7 January 2021

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.403

1 reference

30 November 2017

1 reference